Prenetics Global Limited Q4 FY2025 Earnings Call

· Earnings call transcript and AI-powered summary

Company Overview

  • 2025 was described as the most transformative year in Prenetics’ history, with a strategic pivot toward becoming a pure-play consumer health company.
  • Record full-year revenue of $92.4 million, up 480% year-over-year from 2024, driven primarily by the explosive success of IM8.
  • Strong balance sheet with $171.1 million in adjusted liquid assets as of February 15, 2026, and zero debt.
  • Clear path to adjusted EBITDA profitability by Q4 2027.

Strategic Actions & Corporate Transformation

  • Divested three noncore businesses:
    • ACT Genomics sold for $72 million in June 2025, with $46 million cash returned to Prenetics.
    • Europa business exited in January 2026 via an all-stock $30 million deal.
    • Insighta 35% stake sold to Tencent for $70 million, with $69 million already received.
  • Bitcoin investment strategy discontinued; current holdings frozen at 510 BTC.
  • Board change: Andy Cheung resigned; Dr. Darshan Shah appointed, bringing longevity and performance expertise.

IM8 Growth Highlights

  • IM8 reached a $120 million annualized revenue run rate within its first year—one of the fastest recorded in the global supplement category.
  • Quarterly revenue progression: from $6 million in Q1 to $27.4 million in Q4 2025.

Continue Reading

Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.

Upgrade to Professional
Operator: Greetings, and welcome to the Prenetics Fourth Quarter and Full Year 2025 Earnings Conference Call. As a reminder, this call is being recorded. Your hosts today are Danny Yeung, Chief Executive Officer and Co-Founder; and Stephen Lo, Chief Financial Officer. Mr. Yeung and Mr. Lo will present results of operations for the fourth quarter and full year ended December 31st, 2025, and provide a corporate update. A press release detailing these results was released today and is available on the Investor Relations section of our company's website, www.prenetics.com. Before we begin the formal presentation. I would like to remind everyone that statements made on the call and webcast may include predictions, estimates and other information that might be considered forward-looking. These statements are made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially and are not guarantee of future performance. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events.

Continue Reading

Unlock the full earnings call transcript with speaker labels and formatted dialogue.

Upgrade to Professional